<DOC>
	<DOCNO>NCT02716662</DOCNO>
	<brief_summary>The purpose study determine AC-1204 safe tolerate subject ALS . The reason investigator want use AC-1204 patient ALS determine , take AC-1204 , body make substance call ketone body . Further , AC-1204 well tolerate , investigator want change amount participant take , determine amount ketone body blood increase accordance increase amount AC-1204 participant take . The investigator want study investigator give AC-1204 mouse ALS , find suggest disease course alter good cause change due presence ketone blood . If AC-1204 proven safe able cause ketone increase blood , investigator likely subsequent study determine presence ketone body slow stop progression disease . However , study design determine AC-1204 stop slow progression ALS . It design determine patient ALS tolerate AC-1204 , ketone body produce amount ketone body produce increase increase dose .</brief_summary>
	<brief_title>Safety Caprylic Triglycerides ALS : A Pilot Study</brief_title>
	<detailed_description />
	<criteria>Familial sporadic ALS diagnose probable , laboratorysupported probable definite accord World Federation Neurology El Escorial criterion , Age 18 old , Capable providing inform consent comply trial procedure , Appel ALS score less 100 , Able stand scale assistance , Willing chart food intake 12 week study , Patients either take Riluzole ( Rilutek ) stable dose 30 day , Not take Coenzyme Q10 stable dose brand 30 day , Absence exclusion criterion . Forced vital capacity &lt; 40 % predict , Dependence mechanical ventilation 12 hour per day , Exposure experimental agent within 30 day entry time trial , Women breastfeed , pregnant planning become pregnant , Women childbearing potential practicing medically accept form contraception , Enrollment another research study within 30 day trial , MiniMental State Exam ( MMSE ) score &lt; 20 , Patients symptomatic cardiac disease hypercholesterolemia , Patients myocardial infarction within 6 month trial , Renal dysfunction define BUN creatinine &gt; 2xULN , Known mitochondrial disease , BMI &lt; 18.5 , Prior use 4:1 ketogenic diet Atkins diet within 1 month trial , Impaired liver function , define AST ALT 3xULN , Patients pacemaker internal electronic medical device , Known allergy hypersensitivity milk soy product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>